查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2089086

生物影像市場：按產品、技術、模式、應用和最終用戶分類－2026-2032年全球市場預測

Bio-imaging Market by Product, Technology, Modality, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物成像市場將成長至 149 億美元，複合年成長率為 10.55%。

主要市場統計數據
基準年 2025 73.8億美元
預計年份：2026年 81.3億美元
預測年份 2032 149億美元
複合年成長率 (%) 10.55%

生物成像市場概覽

隨著生物醫學研究、精準診斷、藥物研發和影像引導醫學的融合，以高解析度視覺化和定量影像分析為核心的生物影像市場正在蓬勃發展。全球慢性疾病負擔日益加重是推動此需求成長的主要因素。根據國際癌症研究機構（IARC）統計，2022年全球新增癌症病例約2,000萬例，預計2050年將達到3,500萬例。這進一步增加了對早期檢測、治療進展監測和長期影像學檢查的需求。

在顯微鏡、磁振造影、電腦斷層掃描、正子斷層掃描、單超音波電腦斷層掃描、超音波成像、光學成像、數位病理學和分子成像等領域，買家優先考慮能夠提高靈敏度、處理能力、可重複性和工作流程效率的系統。生物成像領域正在發生變革性變化。

生物成像領域正從獨立儀器轉向聯網的、軟體定義的成像生態系統。尤其是在多體學、空間生物學和精準腫瘤學領域，隨著更豐富的成像環境變得日益重要，實驗室和醫院對能夠整合影像擷取、註釋、儲存、分析和符合規範的報告功能的互通平台的需求也日益成長。

人工智慧在生物成像領域的累積影響

人工智慧透過改進影像重建、降噪、分割、抗蝕劑、分診和生物標記定量等技術，正在生物成像領域產生累積的協同效應。預計到2024年，美國FDA核准的AI/ML賦能醫療設備數量將超過950種，其中放射學領域將佔最大佔有率。這表明演算法成像已從實驗階段邁向規範的臨床應用階段。

生物成像領域的關鍵區域見解

亞太地區發展勢頭強勁，這得益於中國龐大的醫院基礎設施、日本在部署先進診斷成像設備方面的卓越成就、印度診斷服務覆蓋範圍的擴大、澳大利亞的轉化研究網路以及韓國的高研發投入。根據經合組織的數據，韓國在研發投入佔GDP的比例上一直保持著世界領先地位。北美仍然是重要的商業化中心，這得益於美國國立衛生研究院（NIH）的大力資助、美國食品藥物管理局（FDA）對診斷成像軟體的核准流程、先進的癌症中心以及對數位病理學、人工智慧放射學、分子成像和雲端醫學成像工作流程的早期應用。

全球生物成像市場關鍵群體分析

在東南亞國協，隨著新加坡、馬來西亞、泰國、印尼、越南和菲律賓等國加大對診斷能力、生物醫學研究園區、醫療旅遊和數位醫療基礎設施的投資，以滿足大規模服務不足人口的需求，醫療需求正在不斷成長。在海灣合作理事會國家，國家轉型策略正在推動高階影像、腫瘤中心、人工智慧驅動的醫院系統和雲端連接診斷技術的發展，尤其是在沙烏地阿拉伯和阿拉伯聯合大公國。在這些國家，醫療現代化是經濟多元化的核心。

主要國家生物成像技術的發展趨勢

美國憑藉其大規模的學術醫療中心、美國國立衛生研究院 (NIH) 支持的研究、創業投資資金、先進的放射學和病理學網路，以及成熟的美國食品藥品監督管理局 (FDA) 對成像設備和人工智慧軟體的法規結構，引領著生物成像領域的創新。加拿大在人工智慧驅動的研究、人群健康成像和公共資助的醫療服務路徑方面表現卓越。墨西哥受益於近岸外包、私人診斷和跨境醫療活動。巴西作為食品藥物管理局最大的醫療保健市場，憑藉其大規模的醫院網路，對腫瘤學、循環系統和影像學的需求也不斷成長。

為生物成像行業的領導者提供的實用建議

產業領導者應優先考慮可互通的影像診斷平台，這些平台能夠連接醫療設備、實驗室資訊系統 (LIS)、影像歸檔和通訊系統 (PACS)、雲端儲存庫、數位病理系統和人工智慧分析。產品藍圖應重點關注檢驗的軟體、監管文件、網路安全、資料來源可追溯性、可審計性以及與 DICOM、HL7、FHIR 和顯微鏡元元資料標準的兼容性。

調查方法

本執行摘要基於二手研究，參考了經核實的公共和機構資訊來源，包括監管資料庫、國家研究津貼項目、癌症統計數據、同行評審的生物醫學影像文獻、臨床影像指南以及公開的政策文件。檢驗的資訊來源包括美國食品藥物管理局 (FDA)、美國國立衛生研究院 (NIH)、國際癌症研究機構 (IARC)、世界衛生組織 (WHO)、經濟合作暨發展組織 (OECD)、歐盟委員會以及各國衛生部門等機構。

結論

生物影像正逐漸成為精準醫療、轉化研究、臨床診斷和藥物創新的基礎。日益加重的疾病負擔、對早期診斷、空間生物學、數位病理學、雲端連接工作流程的需求，以及人工智慧（AI）在成像流程中的快速整合，共同塑造了這個市場。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 生物影像市場：依產品分類

  • 影像系統
  • 裝置
    • CT掃描儀
    • 核磁共振造影系統
    • 超音波診斷設備
  • 試劑
  • 軟體
    • 資料管理軟體
    • 影像分析軟體

第8章：生物影像市場：依技術分類

  • 內視鏡檢查
  • 磁振造影
  • 核醫學影像
  • 手術顯微鏡
  • 超音波
  • X光影像

第9章：生物影像市場：依影像方式分類

  • 2D成像
  • 3D成像

第10章：生物影像市場：依應用領域分類

  • 臨床診斷
  • 藥物發現
  • 研究
  • 治療

第11章：生物影像市場：依最終用戶分類

  • 門診手術中心
  • 診斷影像中心
  • 醫院和診所

第12章 生物影像市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：生物影像市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 生物影像市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • BaySpec, Inc.
  • Bracco SpA
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Digirad Corporation
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi Medical Corporation
  • HT BioImaging Ltd
  • iThera Medical GmbH
  • Kitware, Inc.
  • Koninklijke Philips NV
  • Lantheus Medical Imaging, Inc.
  • M Squared Lasers Ltd.
  • MARS Bioimaging Limited
  • Medtronic PLC
  • MobileODT Ltd by Liger Medical LLC
  • Perspectum Ltd.
  • Quibim, SL
  • RadNet, Inc.
  • Rivanna Medical, Inc.
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers AG
Product Code: MRR-710B1F0AC3D1

The Bio-imaging Market is projected to grow by USD 14.90 billion at a CAGR of 10.55% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.38 billion
Estimated Year [2026] USD 8.13 billion
Forecast Year [2032] USD 14.90 billion
CAGR (%) 10.55%

Bio-Imaging Market Introduction

The bio-imaging market is expanding as biomedical research, precision diagnostics, drug discovery, and image-guided care converge around higher-resolution visualization and quantitative image analytics. Demand is supported by the growing global burden of chronic disease; the International Agency for Research on Cancer reported about 20 million new cancer cases in 2022 and projects the total could rise to 35 million by 2050, reinforcing the need for earlier detection, treatment monitoring, and longitudinal imaging.

Across microscopy, MRI, CT, PET, SPECT, ultrasound, optical imaging, digital pathology, and molecular imaging, buyers are prioritizing systems that improve sensitivity, throughput, reproducibility, and workflow efficiency. Transformative Shifts in the Bio-Imaging Landscape

The bio-imaging landscape is shifting from standalone instruments to connected, software-defined imaging ecosystems. Laboratories and hospitals are increasingly seeking interoperable platforms that combine image capture, annotation, storage, analytics, and compliance-ready reporting, especially as multi-omics, spatial biology, and precision oncology require richer imaging context.

Funding and policy are also reshaping adoption. Horizon Europe's EUR 95.5 billion research program, the U.S. Cancer Moonshot, national precision medicine initiatives, and rising investment in digital pathology are accelerating translational imaging. At the same time, stricter data governance, cybersecurity, and medical device regulations are pushing vendors to build validated, auditable, privacy-preserving, and secure imaging workflows.

Cumulative Impact of Artificial Intelligence on Bio-Imaging

Artificial intelligence is becoming a cumulative force multiplier in bio-imaging by improving image reconstruction, denoising, segmentation, classification, registration, triage, and biomarker quantification. The U.S. FDA's public list of AI/ML-enabled medical devices surpassed 950 authorizations in 2024, with radiology representing the largest share, demonstrating how algorithmic imaging has moved from experimentation to regulated clinical use.

In research environments, AI supports high-content screening, cell phenotyping, tissue microenvironment analysis, digital pathology review, and automated microscopy quality control. The strongest opportunities will come from explainable AI models, curated and representative datasets, human-in-the-loop validation, and multimodal pipelines that integrate imaging with genomics, proteomics, electronic health records, and laboratory information systems.

Key Regional Insights for Bio-Imaging

Asia-Pacific is gaining momentum through China's scale in hospital infrastructure, Japan's advanced imaging installed base, India's expanding diagnostic access, Australia's translational research networks, and South Korea's high R&D intensity; OECD data consistently place South Korea among the world's highest research-and-development investors as a share of GDP. North America remains a leading commercialization hub because of strong NIH funding, FDA pathways for imaging software, advanced cancer centers, and early adoption of digital pathology, AI radiology, molecular imaging, and cloud-based medical imaging workflows.

Europe benefits from Horizon Europe, the European Health Data Space agenda, and strong academic-industry imaging clusters in Germany, France, the United Kingdom, Italy, and Spain, while EU medical device rules are increasing the importance of clinical evidence and post-market surveillance. Latin America is advancing through Brazil and Mexico's private diagnostics growth and oncology infrastructure needs, while the Middle East is supported by GCC hospital modernization programs, specialty care expansion, and national digital health strategies. Africa's opportunity is tied to portable ultrasound, tele-imaging, tuberculosis and infectious disease imaging, maternal health applications, and public-private capacity building to improve access in resource-constrained settings.

Key Group Insights Across Global Bio-Imaging Markets

ASEAN demand is rising as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines invest in diagnostics capacity, biomedical research parks, medical tourism, and digital health infrastructure for large, underserved populations. The GCC is advancing premium imaging, oncology centers, AI-enabled hospital systems, and cloud-connected diagnostics through national transformation strategies, particularly in Saudi Arabia and the United Arab Emirates, where healthcare modernization is a core component of economic diversification.

The European Union provides scale through harmonized research funding, cross-border data policy, and strong biomedical networks, although MDR and IVDR compliance increases evidence expectations for imaging software and diagnostic workflows. BRICS countries broaden opportunity through large patient populations, expanding hospital capacity, scientific research output, and local manufacturing ambitions, while G7 markets remain innovation leaders in premium imaging, reimbursement sophistication, clinical validation, and academic translation. NATO countries add defense-health relevance through trauma imaging, field diagnostics, medical readiness, and resilient medical supply chains that support both civilian and emergency-care bio-imaging applications.

Key Country Insights in Bio-Imaging

The United States leads in biomedical imaging innovation due to large academic medical centers, NIH-backed research, venture funding, advanced radiology and pathology networks, and a mature FDA framework for imaging devices and AI-enabled software. Canada contributes strengths in AI research, population health imaging, and publicly funded care pathways; Mexico benefits from nearshoring, private diagnostics, and cross-border healthcare activity; and Brazil is Latin America's largest healthcare market, with rising oncology, cardiology, and imaging demand supported by a large hospital base.

In Europe, the United Kingdom, Germany, France, Italy, Spain, and Russia each support demand through hospital modernization, research institutions, and national screening needs, with Germany standing out for engineering, medtech manufacturing, and advanced imaging adoption. The United Kingdom has strengths in genomics-linked imaging research and NHS digital transformation, France supports oncology and nuclear medicine capabilities, Italy and Spain are improving diagnostic capacity across public and private networks, and Russia maintains demand through large tertiary-care systems. In Asia-Pacific, China and India provide scale through expanding healthcare access and chronic disease needs, Japan and South Korea deliver advanced technology adoption and aging-population imaging demand, and Australia contributes high-quality clinical research, cancer imaging networks, population screening programs, and digital health readiness.

Actionable Recommendations for Bio-Imaging Industry Leaders

Industry leaders should prioritize interoperable imaging platforms that connect instruments, laboratory information systems, PACS, cloud repositories, digital pathology systems, and AI analytics. Product roadmaps should emphasize validated software, regulatory documentation, cybersecurity, data provenance, auditability, and compatibility with DICOM, HL7, FHIR, and microscopy metadata standards.

Commercial teams should align offerings with regional evidence requirements, clinical workflows, and buyer economics. In mature markets, differentiation should focus on automation, AI performance, reproducibility, image quality, workflow integration, and total cost of ownership. In emerging markets, portable systems, training, remote support, leasing models, ruggedized equipment, and public-private partnerships can unlock adoption while improving access to biomedical imaging.

Research Methodology

This executive summary is grounded in secondary research from verified public and institutional sources, including regulatory databases, national research funding programs, cancer statistics, peer-reviewed biomedical imaging literature, clinical imaging guidelines, and publicly available policy documents. Sources assessed include agencies such as the FDA, NIH, IARC, WHO, OECD, European Commission, and national health authorities.

The analysis applies a structured market intelligence approach, combining demand-side healthcare indicators, technology adoption signals, regulatory developments, procurement trends, research funding patterns, and regional macroeconomic context. Insights were triangulated across clinical imaging, life science imaging, digital pathology, high-content screening, molecular imaging, preclinical imaging, and AI image analysis to identify durable bio-imaging market drivers without relying on market size, share, or forecast assumptions.

Conclusion

Bio-imaging is becoming a foundational layer of precision medicine, translational research, clinical diagnostics, and pharmaceutical innovation. The market is being shaped by higher disease burden, demand for earlier diagnosis, spatial biology, digital pathology, cloud-connected workflows, and the rapid integration of artificial intelligence into imaging pipelines.

Sustained progress will depend on trust, validation, interoperability, cybersecurity, and measurable workflow value. Organizations that combine high-quality imaging hardware with compliant software, AI-ready data infrastructure, robust clinical evidence, and region-specific commercialization strategies will be best positioned to lead the next phase of the global bio-imaging market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Bio-imaging Market, by Product

  • 7.1. Imaging Systems
  • 7.2. Instruments
    • 7.2.1. CT Scanners
    • 7.2.2. MRI Machines
    • 7.2.3. Ultrasound Devices
  • 7.3. Reagents
  • 7.4. Software
    • 7.4.1. Data Management Software
    • 7.4.2. Image Analysis Software

8. Bio-imaging Market, by Technology

  • 8.1. Endoscopy
  • 8.2. Magnetic Resonance Imaging
  • 8.3. Nuclear Imaging
  • 8.4. Surgical Microscopy
  • 8.5. Ultrasound
  • 8.6. X-ray Imaging

9. Bio-imaging Market, by Modality

  • 9.1. 2D Imaging
  • 9.2. 3D Imaging

10. Bio-imaging Market, by Application

  • 10.1. Clinical Diagnostics
  • 10.2. Drug Discovery
  • 10.3. Research
  • 10.4. Therapeutics

11. Bio-imaging Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals & Clinics

12. Bio-imaging Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Bio-imaging Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bio-imaging Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. BaySpec, Inc.
  • 16.2. Bracco S.p.A.
  • 16.3. Bruker Corporation
  • 16.4. Canon Medical Systems Corporation
  • 16.5. Digirad Corporation
  • 16.6. Esaote S.p.A
  • 16.7. Fujifilm Holdings Corporation
  • 16.8. GE HealthCare Technologies, Inc.
  • 16.9. Hitachi Medical Corporation
  • 16.10. HT BioImaging Ltd
  • 16.11. iThera Medical GmbH
  • 16.12. Kitware, Inc.
  • 16.13. Koninklijke Philips N.V.
  • 16.14. Lantheus Medical Imaging, Inc.
  • 16.15. M Squared Lasers Ltd.
  • 16.16. MARS Bioimaging Limited
  • 16.17. Medtronic PLC
  • 16.18. MobileODT Ltd by Liger Medical LLC
  • 16.19. Perspectum Ltd.
  • 16.20. Quibim, S.L.
  • 16.21. RadNet, Inc.
  • 16.22. Rivanna Medical, Inc.
  • 16.23. Samsung Medison Co., Ltd.
  • 16.24. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-IMAGING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BIO-IMAGING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BIO-IMAGING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BIO-IMAGING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BIO-IMAGING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BIO-IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CT SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CT SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MRI MACHINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MRI MACHINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MRI MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEAR IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEAR IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEAR IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL MICROSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL MICROSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL MICROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL X-RAY IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL X-RAY IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL X-RAY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL 2D IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL 2D IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL 2D IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL 3D IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL 3D IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL 3D IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BIO-IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GCC BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 139. GCC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 140. GCC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. GCC BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 143. GCC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GCC BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. G7 BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. G7 BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 165. G7 BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. G7 BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. G7 BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NATO BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. NATO BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 171. NATO BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 172. NATO BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. NATO BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 175. NATO BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NATO BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. CANADA BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CANADA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 188. CANADA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 189. CANADA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 190. CANADA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. CANADA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 192. CANADA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. CANADA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. MEXICO BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. MEXICO BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 196. MEXICO BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 197. MEXICO BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 198. MEXICO BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. MEXICO BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 200. MEXICO BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. MEXICO BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. BRAZIL BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. BRAZIL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 204. BRAZIL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 205. BRAZIL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 206. BRAZIL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. BRAZIL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 208. BRAZIL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. BRAZIL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED KINGDOM BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GERMANY BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. GERMANY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 220. GERMANY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 221. GERMANY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 222. GERMANY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. GERMANY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 224. GERMANY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. GERMANY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. FRANCE BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. FRANCE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 228. FRANCE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 229. FRANCE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 230. FRANCE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. FRANCE BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 232. FRANCE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. FRANCE BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. RUSSIA BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. RUSSIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 236. RUSSIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 237. RUSSIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 238. RUSSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. RUSSIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 240. RUSSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. RUSSIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. ITALY BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. ITALY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 244. ITALY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 245. ITALY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 246. ITALY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. ITALY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 248. ITALY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. ITALY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. SPAIN BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. SPAIN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 252. SPAIN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 253. SPAIN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 254. SPAIN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. SPAIN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 256. SPAIN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. SPAIN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. INDIA BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. INDIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 268. INDIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 269. INDIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 270. INDIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. INDIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 272. INDIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. INDIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. JAPAN BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. JAPAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 276. JAPAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 277. JAPAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 278. JAPAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. JAPAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 280. JAPAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. JAPAN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. AUSTRALIA BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. AUSTRALIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 284. AUSTRALIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 285. AUSTRALIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 286. AUSTRALIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. AUSTRALIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 288. AUSTRALIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. AUSTRALIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. SOUTH KOREA BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 292. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 293. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 294. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 296. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)